Bridger Management Llc - Net Worth and Insider Trading
Bridger Management Llc Net Worth
The estimated net worth of Bridger Management Llc is at least $198,351 dollars as of 2024-12-27. Bridger Management Llc is the 10% Owner of Cardiff Oncology Inc and owns about 45,703 shares of Cardiff Oncology Inc (CRDF) stock worth over $198,351. Details can be seen in Bridger Management Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bridger Management Llc has not made any transactions after 2015-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bridger Management Llc
Bridger Management Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bridger Management Llc owns 3 companies in total, including Cardiff Oncology Inc (CRDF) , Response Genetics Inc (RGDXQ) , and Jazz Pharmaceuticals PLC (JAZZ) .
Click here to see the complete history of Bridger Management Llc’s form 4 insider trades.
Insider Ownership Summary of Bridger Management Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2015-07-17 | 10 percent owner |
| RGDXQ | Response Genetics Inc | 2015-11-18 | 10 percent owner |
| JAZZ | Jazz Pharmaceuticals PLC | 2008-03-13 | 10 percent owner |
Bridger Management Llc Latest Holdings Summary
Bridger Management Llc currently owns a total of 1 stock. Bridger Management Llc owns 45,703 shares of Cardiff Oncology Inc (CRDF) as of July 17, 2015, with a value of $198,351.
Latest Holdings of Bridger Management Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2015-07-17 | 45,703 | 4.34 | 198,351 |
Holding Weightings of Bridger Management Llc
Bridger Management Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Bridger Management Llc has made a total of 0 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years. The most-recent trade in Cardiff Oncology Inc is the acquisition of 1,944 shares on July 17, 2015, which cost Bridger Management Llc around $1 Million.
Insider Trading History of Bridger Management Llc
- 1
Bridger Management Llc Trading Performance
GuruFocus tracks the stock performance after each of Bridger Management Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bridger Management Llc is -2.98%. GuruFocus also compares Bridger Management Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bridger Management Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bridger Management Llc's insider trading performs compared to the benchmark.
Performance of Bridger Management Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.34 | | | | | |
| Relative Return to S&P 500(%) | -4.77 | | | | | |
Bridger Management Llc Ownership Network
Bridger Management Llc Owned Company Details
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
Bridger Management Llc is the 10 percent owner of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Financial Officer James E. Levine , Chief Medical Officer Fairooz Kabbinavar , and Chief Scientific Officer Mark Erlander .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, Bridger Management Llc made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 414,565 shares made by Gary W Pace , a net purchase of 10,000 shares made by Renee P Tannenbaum , and a net purchase of 7,716 shares made by James E. Levine .
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 379,331 shares, with a net purchase of 379,331 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 432,281 shares were bought by its insiders, resulting in a net purchase of 432,281 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
Bridger Management Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Bridger Management Llc. You might contact Bridger Management Llc via mailing address: 90 Park Avenue, 40th Floor, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
